Not all products or features are available in all markets.

  • Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

How precision care can support improved outcomes for women

gehq-17

Research shows women’s diagnoses tend to arrive later than men’s: symptoms can be explained away, a standard test might miss what’s there, or a disease develops quietly over years. How can precision care lessen the wait and help improve a woman's health outcomes?

Video Thumbnail

Women spend about 25 percent more of their lives in poor health than men. Time explains part of the gap: a Danish study of 6.9 million people found that women received diagnoses later than men for 770 diseases, by about four years on average.

People tend to act on symptoms, yet women’s symptoms are often attributed to something else, understood later or they don’t surface for years. Whether it is breast cancer, Alzheimer’s disease or heart disease, precision care works under a different premise: understanding what makes each patient different, and detecting, diagnosing and treating at the right time.

Breast cancer: Finding tumors small

Jenn Louviere Kilmurray was breastfeeding when she found a lump. Clinicians initially treated it as mastitis. “I went into the doctor about five or six times before I was referred for imaging,” she says. The diagnosis was stage 3 breast cancer.

Cancer staging is what that time costs: the longer a cancer goes undiagnosed, the further it can spread. In the United States, five-year relative survival exceeds 99 percent when breast cancer stays in the breast but drops to 32 percent after it spreads to distant organs. That is why, says Professor Fiona Gilbert, an academic radiologist at the University of Cambridge in Cambridge, United Kingdom, “we need to find the cancers when they’re very small, before they’ve spread.”

But standard screening has a blind spot: more than 70 percent of all breast cancers occur in dense breast tissue, and dense tissue and tumors look similar on a mammogram. For Jenn, that blind spot was personal: “Dense breast tissue runs in my family,” she says, “and I think that [made] diagnosis harder.” 

Dr. Gilbert led the BRAID trial, which provided evidence that women with dense breast tissue could benefit from supplemental imaging. “We showed it was the contrast techniques, contrast mammogram or an MRI scan, which would find the cancers early when they’re really small,” she says. For women like Jenn, that could mean less time waiting for an answer.

Alzheimer’s and early detection: A 20-year head start

Genevieve’s mother, Phyllis, spent many years at an insurance company. Then, on her drive home from work, she suddenly couldn’t find her way. Genevieve later learned that her mother had seen a neurologist 18 months before the family noticed signs of cognitive impairment. Clinicians initially attributed the symptoms to stress or anxiety. Mild cognitive impairment was diagnosed later, and a diagnosis of Alzheimer’s disease shortly followed.

Research has shown that  Alzheimer’s can begin 20 years or more before memory loss and other symptoms develop, driven in part by beta-amyloid, a protein fragment that clumps into plaques outside brain cells and can be measured on brain scans and in blood and spinal fluid. Yet underdiagnosis is most pronounced at the earliest stages of dementia, when symptoms are mild—the stage when treatment and planning may be most effective.

Why is early diagnosis for Alzheimer’s disease important: Amyloid-targeting therapies can slow progression in people with mild symptoms, and one study found they may extend independence in everyday activities by 10 to 13 months.

And women carry much of the weight. “[Alzheimer’s disease] remains a disproportionately women’s disease,” Dr. Suchandrima Banerjee, General Manager, Neurology Care Pathway at GE HealthCare, says, as the lifetime risk at age 45 is 1 in 5 for women versus 1 in 10 for men.

Genevieve knows what an earlier answer buys: time. “I feel that maybe for a year or two there was a plateau,” she says. “And that was when we had a lot of time together.”

Heart disease: Why a woman's heart might be misdiagnosed

Joanna Markle, a secondary school teacher in Pittsburgh, Pennsylvania, began feeling tired in her mid-forties. When she went to the doctor with fatigue and heart palpitations, “I was told it was anxiety. I was told it was middle age. I was told it was normal.” A heart attack followed.

Dr. Gosia Wamil, Consultant Cardiologist at Nuffield Health, explains why. “In women in particular, symptoms of cardiovascular disease can often be [attributed] to perimenopause, aging or getting tired, stressed,” she says. “And for this reason, it is sometimes challenging to make the initial diagnosis with symptoms alone.”

According to a recent study, women are 50 percent more likely to be misdiagnosed with a heart attack than men. Emergency care shows the same pattern: a 2026 American Heart Association scientific statement finds premenopausal women face delays in care and diagnosis, and limited trial data leaves clinicians less certain on how to proceed. 

Joanna never expected any of it. “I didn’t have a heart condition.” But disease can be present long before symptoms. “With imaging such as CT coronary angiography, we can describe the fatty depositions within the coronary arteries very early, many years before any symptoms,” Dr. Wamil says. That view is where precision care can help.

Precision care can help close the diagnosis gap for women

Precision care tailors how and when a person is tested, diagnosed and treated to their own biology and risk. “I really believe that we should be changing the screening programs from a one-size-fits-all to a more personalized approach,” Dr. Gilbert says.

Research is exploring what this could look like in each disease. In breast cancer, the BRAID trial found that supplemental scans for women with dense breasts detected 17 to 19 additional cancers per 1,000 women after a normal mammogram. In heart disease, clinical guidelines identify female-specific factors, such as pregnancy complications and early menopause, that may inform risk assessment. In Alzheimer’s disease, studies show that biological changes can be measured on brain scans and in blood and spinal fluid during the 20 years or more before symptoms.

Imaging technologies, Dr. Banerjee says, “provide these powerful tools that can help clinicians make that early, accurate diagnosis.” The signal is already there, and precision care can help enable health systems to act at the right time, with the right information, based on a woman's first sense that something is wrong.

Get in touch

Have a question? We would love to hear from you.

Sign Up

We’re sorry, a problem occurred with the form. Please try again.
Thank you for your inquiry

We will be in touch soon.

Something went wrong

We will check and get back.

JB40725XX November 2026